Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;1(4):209-216.
doi: 10.1016/j.jacig.2022.05.012. Epub 2022 Aug 13.

Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy

Dilawar Khokhar  1 , Kelly M O'Shea  1 , Cem Akin  1 , James L Baldwin  1 , Mariel R Benjamin  1 , Rajan Ravikumar  1 , Mirie Hosler  1 , Marc S McMorris  1 , Georgiana M Sanders  1 , Jonathan P Troost  2 , Alan P Baptist  1 , Deborah T Oberdoerster  1 , Anna Kovalszki  1
Affiliations

Vaccination counseling with and without excipient skin testing in patients with suspected allergic reactions to mRNA COVID-19 vaccines and patients with atopy

Dilawar Khokhar et al. J Allergy Clin Immunol Glob. 2022 Nov.

Abstract

Background: Allergic reactions have been reported with mRNA vaccines for COVID-19 prevention. Patients perceived to be at higher risk for a reaction may be referred to an allergist, although evaluation strategies may differ between allergists.

Objective: Our aim was to determine outcomes of COVID-19 vaccinations in patients evaluated by an allergist using different approaches.

Methods: We conducted a retrospective case series evaluation of 98 patients seen at the University of Michigan Allergy Clinic for concerns regarding COVID-19 vaccination. Of these 98 patients, 34 underwent skin testing with polyethylene glycol (PEG) 2000 with or without PEG 3350/polysorbate 80 testing.

Results: Of the 34 patients on whom skin testing was performed, 16 underwent testing before vaccination and 18 underwent testing after a reported vaccine-related event. One patient had a positive skin testing result in response to PEG 3350 following a vaccination reaction and natural infection and was advised against a second dose. One patient with a significant history concerning of anaphylaxis in response to PEG had positive results of testing to identify allergy to PEG 2000, PEG 3350, and polysorbate 80 and was advised against vaccination. Of the 98 patients, 63 (64%) tolerated COVID-19 vaccination without complication after evaluation by an allergist.

Conclusion: No significant differences were found between vaccination counseling with and without skin testing to excipients. Patients who presented before the first dose of vaccination were more likely to proceed with COVID-19 vaccination and tolerate vaccination without complication.

Keywords: COVID-19 vaccine; COVID-19, Coronavirus disease 2019; DMG-PEG 2000, 1,2-Dimyrtistoyl-rac-glycero-3-methoxypolyethylene glycol-2000; NF, National Formulary; PEG, Polyethylene glycol; polyethylene glycol; polysorbate 80; vaccine allergy.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flowchart of the study.
See this image and copyright information in PMC

References

    1. Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–154. - PMC - PubMed
    1. Li Y.D., Chi W.Y., Su J.H., Ferrall L., Hung C.F., Wu T.C. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020;27:104. - PMC - PubMed
    1. Oliver S.E., Gargano J.W., Marin M., Wallace M., Curran K.G., Chamberland M., et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1922–1924. - PMC - PubMed
    1. Oliver S.E., Gargano J.W., Marin M., Wallace M., Curran K.G., Chamberland M., et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Moderna COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69:1653–1656. - PMC - PubMed
    1. Oliver S.E., Gargano J.W., Scobie H., Wallace M., Hadler S.C., Leung J., et al. The Advisory Committee on Immunization Practices' interim recommendation for use of Janssen COVID-19 vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021;70:329–332. - PMC - PubMed